13 Hrs
Source:
وكالة الأنباء العمانية
وكالة الأنباء العمانية
Ready to play
Ready to play
Clinical trial results showed that an experimental immunosuppressive drug developed by Elidon Pharmaceuticals outperformed the current standard treatment for kidney transplant patients, potentially representing a significant advancement in their care.
Notice: This Is an AI-Generated Summary
Comments (0)